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Docetaxel-loaded acetic acid conjugated Cordyceps sinensis polysaccharide (DTX-AA-CSP) 
nanoparticles were prepared through dialysis and their release rates in vitro, particle sizes, zeta 
potentials, drug loading capacities, and encapsulation efficiencies were characterized for the synthesis 
of AA-modified CSPs from traditional Chinese medicine Cordyceps sinensis (Berk.) Sacc. Then, the 
AA-modified CSPs were characterized by 1H-NMR and FT-IR. Furthermore, the biocompatibility of 
the delivery carrier (AA-CSP nanoparticles) was assessed on human umbilical vein endothelial cells. 
In vitro antitumor activity studies on DTX-AA-CSP nanoparticles were conducted on the human liver 
(HepG2) and colon cancer cells (SW480). The DTX-AA-CSP nanoparticles were spherical and had 
an average size of 98.91±0.29 nm and zeta potential within the −19.75±1.13 mV. The encapsulation 
efficiency and loading capacity were 80.95%±0.43% and 8.09%±0.04%, respectively. In vitro, DTX 
from the DTX-AA-CSP nanoparticles exhibited a sustained release, and the anticancer activities 
of DTX-AA-CSP nanoparticles against SW480 and HepG2 were significantly higher than those 
of marketed docetaxel injection (Taxotere®) in nearly all the tested concentrations. The AA-CSP 
nanoparticles showed good biocompatibility. This study provided a promising biocompatible delivery 
system for carrying antitumor drugs for cancer therapy.
Keywords: Docetaxel. Cordyceps sinensis polysaccharide. Nanoparticles. Antitumor efficacy. 
Biocompatibility.
INTRODUCTION
Anticancer drugs used in tumor treatment are 
nonselectively target normal and cancer cells and thus 
often cause toxic side effects. The highly effective 
delivery of hydrophobic antitumor agents, such as 
paclitaxel or docetaxel, is often impeded by their poor 
water solubility, rapid phagocytic and renal clearance, 
and systemic toxicity. Therefore, studies for reducing the 
toxicities and improving the efficacies of various drug 
delivery systems, such as self-emulsifying drug delivery 
systems, liposomes, microspheres, and polymeric 
micelle nanoparticles, have been conducted (Feeney, 
2016; Pakulska, Miersh, Shoichet, 2016; Torchilin, 2014; 
Pattni, Chupin, Torchilin, 2015).
Recently, micelle nanoparticles that consist of 
amphiphilic block copolymers and can self-assemble 
in aqueous media have received great attention as 
gene and drug nanocarriers because of their special 
characteristics, such as capability to prolong blood 
circulation and core-shell structures (Shi, 2010; 
Shi, 2017; Segal et al., 2017; McHale, 2012). A self-
assembled micelle nanoparticle has a unique core-
shell backbone composed of a hydrophobic core and 
hydrophilic shell (Nishikawa, Akiyoshi, Sunamoto, 
1996). The monolayer structure can form an outer 
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hydrophilic shell and inner hydrophobic core in an 
aqueous medium through self-assembly, and the special 
core-shell structure can incorporate and protect drugs in 
an aqueous medium. The half-time of a self-assembled 
nanoparticle is prolonged by its special hydrophilic 
shell during blood circulation; the shell enables 
the nanoparticle to escape from reticuloendothelial 
system uptake after intravenous injection (Powers et 
al., 2017). Amphiphilic block copolymers are usually 
obtained through the following techniques: chemical 
crosslinking of monomers, physical self-assembly of 
macromolecules, and polymerization of monomers in 
a homogeneous medium (Xu et al., 2015). However, 
synthetic polymers sometimes exhibit material 
toxicity, high immunogenicity, and nondegradability, 
which restrict their application in drug delivery 
systems. These disadvantages can be offset by using 
natural polymers (e.g., polysaccharides), which have 
low immunogenicity, good biocompatibility, and 
biodegradability and can be easily modified and used 
to improve the capacities of drug delivery systems 
(Liao et al., 2005). Pullulan, modified with cholesterol 
and amino groups as a drug delivery vehicle of 
anticancer drug (docetaxel), has high antitumor 
efficacy and strong lung cancer cell inhibition in vitro 
(Singh, Kaur, Kennedy, 2015). Meanwhile, Kamel et 
al. (2008) used propylene oxide to modify a cellulose 
hydroxyl group and prepared hydroxypropyl cellulose 
to enhance cellulose solubility and control drug 
release. Chitosan-based, drug-loaded micelles exhibit 
a remarkably higher inhibition for cancer cells in vitro 
than reference drugs, which are related to enhance drug 
internalization (Agnihotri, Mallikarjuna, Aminabhavi, 
2004). Cordyceps sinensis (Berk.) Sacc is widely used 
in China as traditional Chinese medicine (TCM) to 
improve the kidney, liver, lung, and immune functions. 
Cordyceps sinensis polysaccharides (CSP) have been 
widely used in biological areas, such as antioxidation, 
immunomodulation, and hypoglycemics (Li et al., 2006; 
Li et al., 2003; Wu et al., 2005; Cheung et al., 2009). 
CSPs have been considered for various pharmaceutical 
applications, such as drug delivery systems. Polymeric 
nanoparticles synthesized by using deoxycholic acid, 
alkyl, and aralkyl have been used to improve the 
hydrophobic property of water-soluble copolymers 
(Lee, 1998). In the present study, amphiphilic polymers 
with possible antitumor application in pharmaceutical 
field were obtained by synthesizing acetic acid 
modified Cordyceps sinensis polysaccharide (AA-
CSP) nanoparticles through a process involving the 
covalent attachment of AA to polysaccharides through 
ester links. AA-CSP was characterized with FT-IR 
spectroscopy and 1H-NMR. Docetaxel (DTX) was 
selected as a model antitumor drug to prepare DTX-AA-
CSP nanoparticles. The detailed molecular structure 
of DTX can be found in Figure 1, and the chemical 
structure and synthetic route of the AA-CSP copolymer 
were depicted in Figure 2. Polydispersity index, 
particle sizes, zeta potentials, drug loading capacity 
(LC), encapsulation efficiency (EE) and in vitro drug 
release were measured. Biocompatibility assay was 
evaluated in human umbilical vein endothelial cells 
(HUVEC) in vitro. Furthermore, in vitro antitumor 
activity studies of DTX-loaded AA-CSP nanoparticles 
were performed in the human liver (HepG2) and colon 
cancer cells (SW480). This study is beneficial to the 
development of polymer micelle nanoparticles based on 
TCM and provides a promising delivery system (AA-
CSP nanoparticles) for antitumor drug delivery.
MATERIAL AND METHODS
Material
Docetaxel injection (Taxotere®) was provided 
by Sanofi Aventis Pharmaceutical Co., Ltd. (Beijing, 
China). Methanol and acetonitrile were purchased from 
Fisher Scientific (Fair Lawn, NJ, USA, chromatographic 
grade). Docetaxel was provided by Meilun Biological 
Technology Co., Ltd (Dalian, China, Purity: 99.89%). 
Cordyceps sinensis polysaccharides were supplied by 
Jilin Medical University (Jilin, China, Purity: 90.89%). 
Dimethyl sulfoxide (DMSO), pyridine, and acetic 
anhydride (AA) were supplied by Energy Chemical 
Co., Ltd. (Shanghai, China). AA was purchased from 
Sinopharm Chemical Reagent Co., Ltd (Beijing, China). 
Dulbecco’s modified eagle medium (DMEM), fetal 
bovine serum (FBS), trypsin, and phosphate buffer 
saline (PBS) were all purchased from Thermo Fisher 
Scientific (Fair Lawn, NJ, USA). 2K was provided 
by Wisent Co., Ltd. (Montreal, QC, Canada). Tween 
80, ethanol, diethyl ether and pyridine were supplied 
by Aladdin Reagent Co., Ltd. (Shanghai, China). 
Membrane filters were purchased from Tianjin Jinteng 
Experiment Equipment Co., Ltd (Tianjin, China), and 
distilled water was supplied by Milli-Q (Germany). All 
the other reagents were of analytical grade, obtained 
commercially. 
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Synthesis of the AA-CSP Copolymer
The AA-CSP graft copolymers were synthesized 
using pyridine, AA, and CSP, as shown in Figure 2. 
CSP (2.0 g) was added in 20 mL of DMSO solution, 
and then the mixed solution was stirred for 2 h at 
54 °C. Pyridine (6 mL) and AA (7.5 mL) were added 
to the mixed solution (20 mL) and reacted for 48 h at 
54 °C. The reaction solution was transferred to an excess 
amount of cold ethanol (10 folds by volume) to obtain 
precipitates, which were recovered by filtration, washed 
with ethanol (100 mL) and diethyl ether (100 mL) three 
times, and then dried in vacuum at 54 °C (Motozato et 
al., 1986). The AA-CSP copolymer yield was 1.02 g.
FT-IR Spectroscopy 
The changes of the chemical composition in 
the surfaces of CSP after conjugation with AA were 
performed on a Thermo IS10 FTIR spectrometer with 
a tablet of powdered KBr and adsorbent in the range of 
400–4000 cm-1 (Thermo, SA) (Xie et al., 2015). 
1H-NMR Spectroscopy
The 1H NMR spectra of the samples (3 mg) were 
determined in DMSO
d6
 (500 μL) using a 400 MHz NMR 
spectrometer (AVIII, Bruker, 400 MHz) at 25 °C(Wu, 
2007). All the spectra were processed with Bruker 
Topspin Version 3.0 software. The degree of substitution 
(DS) of AA-CSP was calculated via l H NMR.
DS was calculated according to the following 
equation:
DS (%)=(Aδ0.85/3)/(Aδ5.15+Aδ4.91)*100%,
where Aδ0.85 was the peak area of methyl protons; 
Aδ5.15 was the peak area of (1 → 6)-linked hydrogen 
FIGURE 1 - Chemical structure of doxetaxel.
FIGURE 2 - Synthetic route of acetic acid (AA) conjugated Cordyceps. sinensis polysaccharides (AA-CSP).
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protons; and Aδ4.91 was the peak area of (1 → 4)-linked 
hydrogen protons.
Development of DTX-Loaded AA-CSP Nanoparticles 
AA-CSP (25 mg) was dissolved in 5 mL of DMSO 
solution, and was transferred into a cellophane membrane 
dialysis bag (Jeong et al., 2006a). Then, the amphiphilic 
molecules of AA-CSP graft copolymers were dialyzed 
with 1.0 L of water each time and were dialyzed for eight 
times. Deionized water (1.0 L) was exchanged every 2 
h for four times and then exchanged every 8 h for four 
times with 100 rpm/min at 25 °C. The nanoparticle 
solution was filtered through a 0.45 mm membrane filter 
and was adjusted to 25 mL by adding deionized water. 
Docetaxel (10 mg) was completely dissolved in 10 mL 
of chloroform/absolute ethanol mixture solvent (1:1, v/v) 
and then slowly added into a nanoparticle solution drop 
by drop under magnetic stirring (100 rpm/min) for 24 h. 
The harvested nanoparticle solution was adjusted to 25 
mL by re-adding deionized water.
Transmission electron microscopy
The surface morphologies of the DTX-AA-CSP 
nanoparticles were observed on a transmission electron 
microscope (JEM-2010, Japan; Jaimuang, 2015). A 
droplet from the nanoparticles was stained with 0.5% 
phosphotungstic acid solution for 10 min and placed 
on a copper grid. Subsequently, the excess solution 
was removed by a filter paper. The sample was dried at 
room temperature before it was characterized. All the 
experiments were performed in triplicate.
Zeta potentials and particle sizes
The particle sizes and zeta potentials of the DTX-
AA-CSP nanoparticles were determined by a dynamic 
light scattering analyzer with a scattering angle of 90° 
(Zetasizer Nano ZS, Malvern Instruments, UK) at 25 °C 
(Guan et al., 2016a). All experiments were performed 
in triplicate, and data were expressed as mean value ± 
standard deviations.
Encapsulation efficiency and loading capacity
The percentage drug loading efficiency of 
DTX in AA-CSP nanoparticles was determined by 
separating the unentrapped drug from nanoparticles 
by centrifugation at 12,000 rpm for 10 min. The clear 
supernatant was determined for the contents of DTX 
by measuring the peak area with a high performance 
liquid chromatography (HPLC) (LC-20AT, Shimadzu) 
at a wavelength of 230 nm. The mobile phase consisted 
of distilled water and acetonitrile at a 45:55 volume 
ratio. All experiments were performed in triplicate. 
The percentage loading capacity and encapsulation 
efficiency were calculated as follows:











))/Weight of copolymer 
micelles*100%,
where DTXt was the total weight of docetaxel; and 
DTXf was the unentrapped docetaxel present in the 
supernatant.
In vitro drug release
The in vitro release profiles of DTX from 
docetaxel injection and DTX-AA-CSP nanoparticles 
were investigated through dialysis. DTX-AA-CSP 
nanoparticles and docetaxel injection were respectively 
suspended in 4 mL of distilled water (100 μg/mL of 
final DTX concentration) and then transferred into 
a cellophane membrane dialysis bag (8–12 kDa). 
The dialysis bag was suspended in 20 mL of pH 6.8 
phosphate buffer saline (PBS) with 0.5% of Tween 
80 under horizontal stirring at 100 rpm/min and 
temperature maintained at 37±0.5 °C (Yanasarn, Sloat, 
Cui, 2009). A sample medium (5 mL) was withdrawn 
at predetermined time points (0, 1, 2, 4, 6, 8, 10, 12, 
24, and 48 h) and was compensated an equal volume 
of fresh PBS medium under the same temperature. The 
content of DTX in the released medium was calculated 
by HPLC at 230 nm. Sink condition was maintained 
during the whole release period. All samples were 
performed in triplicate. 
Biocompatibility study of AA-CSP nanoparticles 
The biocompatibility of delivery carriers (AA-CSP 
nanoparticles) was analyzed via MTT assay29 using 
HUVEC cells. Cells were grown in 24-well plates at 
an initial density of 2×105 cells/well with 100 μL of 
F12K containing 10% FBS, 0.4% heparin sodium, and 
1% endothelial cell growth supplement, which were 
Development, in vitro biocompatibility, and antitumor efficacy of acetic acid-modified Cordyceps sinensis polysaccharide nanoparticle drug delivery system
Braz. J. Pharm. Sci. 2020;56: e18470 Page 5/13
incubated for 24 h at 37 °C in a 5% CO
2
 condition. 
The medium was placed by samples of various 
concentrations of AA-CSP nanoparticles (0.05, 0.2, 
and 1 mg/mL) and in pace with five paralleled wells. 
After 72 h of incubation, 20 μL of MTT solution (5 mg/
mL) was placed to each well of the plate. The medium 
was discarded after 4 h of incubation, 200 μL/well of 
DMSO was added to dissolve the formazan crystals in 
the plate, and the absorbance was measured at 492 nm 
by a microplate reader (FL600, Bio-Tek Inc., Winooski, 
VT). The cell viability (%) was calculated according to 
the following equation: 










where OD492, sample represents the measurement 
from the AA-CSP nanoparticles, docetaxel injection 
(Taxotere®); and DTX-AA-CSP nanoparticles; OD492, 
control represents from the cells treated with incubated 
solution; and OD492, blank represents the incubated 
solution.
In vitro anticancer activity
The anticancer activities of AA-CSP nanoparticles, 
docetaxel injection (Taxotere®), and DTX-AA-CSP 
nanoparticles were measured in HepG2 and SW480 
cells using the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyl tetrazoniumbromide) assay (Mosmann, 1983). 
Briefly, SW480 and HepG2 cells with 2×105 cells/well 
of initial density were placed in a 96-well plate with 100 
μL of DMEM containing 10% FBS and were incubated 
for 24 h at 37 °C in a 5% CO
2
 condition. Cells were 
exposed in a series of doses of AA-CSP nanoparticles, 
docetaxel injection (Taxotere®), and DTX-AA-CSP 
nanoparticles at concentrations ranging from 0.0005 μg/
mL to 0.5 μg/mL. After 72 h of incubation, 20 μL of 
MTT solution (5 mg/mL) was placed on each well of 
the plate. The medium was discarded after incubating 
for 4 h, 200 μL/well of DMSO was added to dissolve 
the formazan crystals in the plate, and the absorbance 
was measured at 492 nm by a microplate reader (FL600, 
Bio-Tek Inc., Winooski, VT). The anticancer activity 
(%) was calculated according to the following equation:










where the OD492, sample represents the measurement 
from the AA-CSP nanoparticles, docetaxel injection 
(Taxotere®), and DTX-AA-CSP nanoparticles; 
OD492, control represents the cells treated with 
incubated solution; and OD492 blank represents the 
incubated solution.
Data analysis
Data were expressed as the mean ± standard 
deviation, and statistical analysis was performed using 
an unpaired Student’s t-test. Data were considered 
significantly different at p<0.05.
RESULTS AND DISCUSSION
FT-IR and 1H-NMR Analysis
FT-IR spectra of CSP and AA-CSP were shown 
in Figure 3. Compared with the spectrum of CSP, an 
obvious change was observed at 1730 cm-1, which 
resembled the existence of the (-OCO-group), and 
the result demonstrated that AA was successfully 
conjugated with CSP during the reaction. The 
broad stretching peak at 3435 cm-1 was attributed to 
hydroxyl groups, and the sharp peak near 1413 cm-1, 
to O-H bending vibration. The band at 1640 cm-1 
could be attributed to the ring stretching of glucose 
(Wang, 2011). The characteristic peak at 1085 cm-1 
suggested the existence of pyran-glycosylated, and the 
absorption peak at 825 cm-1 suggested the presence of 
the α-glycosidic linkage. The FT-IR spectrum of CSP 
and the above composition analysis indicated that CSP 
was mainly composed of α-glycosidic, bond-linked 
glucopyranose.
Figures 4 and 5 showed the 1H NMR spectrum of 
CSP and AA-CSP in DMSO-d6, respectively, where 
δ1.24 ppm was the peak of methylene protons, and 
δ0.85 ppm was the peak of methyl protons. Hydroxyl 
proton signals were observed at δ3.89–5.15 ppm in the 
1H NMR spectrum of CSP. δ5.15 ppm was the peak area 
of (1 → 6)-linked hydrogen protons, and δ4.91 ppm 
was the peak area of (1 → 4)-linked hydrogen proton in 
CSP(Cheong, 2016). Furthermore, the DS of AA-CSP 
was 13.88%, which could be calculated from the peak 
areas of their 1H NMR signals, respectively (Table I). 
In this study, CSP was substituted by 13.88 stearic acid 
groups per 100 glucoside units.
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FIGURE 3 - Fourier transform infrared (FT-IR) spectra of AA-CSP (A) and CSP (B). FTIR experiments were recorded at 25 °C 
on Shimadzu 8300 FTIR spectrometer with a KBr tablet with the range of 400 - 4000 cm-1.
FIGURE 4 - 1H nuclear magnetic resonance (1H-NMR) spectra of CSP in DMSO
d6
. 
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FIGURE 5 - 1H nuclear magnetic resonance (1H-NMR) spectra of AA-CSP in DMSO
d6
. 1H-NMR spectra indicated the generation 
of methyl (δ
0.85
) protons after the addition of AA to the reaction mixture containing CSP.
TABLE I - Peak area of δ5.15, δ4.91, δ0.85 1H NMR signals
Sample Aδ5.15 Aδ4.91 Aδ0.85
AA-CSP 1.01 1.40 1.00
Morphology analysis, zeta 
potentials, and particle sizes 
Amphiphilic copolymers, such as hydrophilic 
polysaccharides and hydrophobic groups, formed 
nanosized carriers with an outer hydrophilic shell 
and inner hydrophobic core structure in an aqueous 
medium (Jeong et al., 2006b). The special property of 
amphiphilic nanoparticles is suitable to incorporate and 
load poorly soluble anticancer drugs. The morphology 
of DTX-AA-CSP nanoparticles was characterized by 
a negative stain on the TEM. The nanoparticles had a 
spherical morphology (Figure 6).
The zeta potential of AA-CSP nanoparticles was 
61.36±1.15 mV, whereas the average size was −19.91±0.75 
nm. The mean zeta potential and the particle size of 
DTX-AA-CSP nanoparticles were 98.91±0.29 nm and 
−19.75±1.13 mV, respectively (Table II). The small 
particle size of nanoparticles (<200 nm) facilitated 
lymphatic transport, avoiding the mononuclear 
phagocyte system uptake, and passively delivering 
the anticancer drugs (Yokoyama et al., 1990). Zeta 
potential is also an important parameter, which reflects 
either the electrostatic repulsion or congregation of the 
nanoparticles. Increase in electrostatic repulsive force 
between nanoparticles can prevent coalescence of the 
nanoparticles from forming large precipitation, which is 
useful in maintaining the dispersion stability of these 
nanoparticles. Compared with that of blank AA-CSP 
nanoparticles, the mean particle size slightly increased, 
whereas zeta potential only changed slightly after DTX 
loading, when the DTX and AA-CSP nanoparticles 
mass ratio changed from 1:20 to 1:10 (w/w).
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FIGURE 6 - Transmission electron microscopy image of DTX-AA-CSP nanoparticles (Magnitude 60000×,scale 200 nm).
TABLE II - The characterization of DTX-AA-CSP nanoparticles
Sample d/c(w/w)a EE(%) LC(%) Average diameter (nm) Zeta potential (mV)
AA-CSP
-- -- -- 61.36±1.15 -19.91±0.75
1:20 85.87±0.57 4.29±0.03 86.40±1.20 -21.05±0.82
1:15 83.55±0.50 5.57±0.03 97.70±1.02 -21.44±0.52
1:10b 80.95±0.43 8.09±0.04 98.91±0.29 -19.75±1.13
1:9 68.97±0.24 7.66±0.03 91.11±0.80 -20.06±0.16
a The weight of drug and carrier(DTX/AA-CSP) self-aggregated nanoparticles (mg/mg)
b The optimized formulation.
Encapsulation efficiency and loading capacity
Table II also showed the effect of different counts 
of DTX on the LC and EE. Results presented that EE 
decreased from 85.87%±0.57% to 80.95%±0.50% 
with the increase of drug verse carrier mass ratio from 
1:20 to 1:10 (w/w) in this investigation. However, the 
LC (from 4.29%±0.03% to 8.09%±0.04%) increased 
with the mass ratio ranging from 1:20 to 1:10, which 
indicated that the DTX-loading ability of AA-CSP 
nanoparticles was enhanced. The drug LC and EE of 
DTX-AA-CSP nanoparticles were 8.09%±0.04% and 
80.95%±0.43%, respectively, when the drug verse 
carrier mass ratio was 1:10. 
When the mass ratio of the drug to carrier was 
1:9, the values of the LC and EE of DTX-AA-CSP 
nanoparticles decreased compared with that when the 
drug to carrier ratio was 1:10. The decreased value 
of LC and EE of the nanoparticles may have resulted 
from the capacity of AA-CSP themselves. The solvent 
polarity of chloroform/ethanol was used to dissolve 
DTX in the emulsion method. Chloroform/ethanol was 
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liable in carrying DTX to enter the hydrophobic cores of 
AA-CSP nanoparticles. Therefore, considering the LC 
and EE, we selected the mass ratio of drug verse carrier 
at 1:10 to prepare the DTX-AA-CSP nanoparticles, with 
the chloroform/ethanol as solvent to dissolve DTX. The 
optimized formulation was repeated in triplicate.
In vitro drug release
The release behavior of docetaxel injection and 
DTX-AA-CSP nanoparticles in vitro was performed in 
the phosphate buffer saline (pH 6.8) solution containing 
0.8% of Tween 80 at 37±0.5 °C. As shown in Figure 7, 
the release percentage of DTX from docetaxel injection 
Taxotere® was faster and higher (77.55%±0.89%) than 
that from DTX-AA-CSP nanoparticles (54.17%±1.08%) 
at 12 h. The DTX-AA-CSP nanoparticles tended to be 
stable even after 12 h. The DTX release percent of DTX-
AA-CSP nanoparticles was 61.94%±1.45% in the first 
24 h and 68.10%±0.71% in 48 h. The release behavior 
of DTX-AA-CSP nanoparticles was lower and slower 
than that of docetaxel injection Taxotere® at the same 
dissolution medium. The difference in DTX release rate 
was mainly due to the core-shell structure of AA-CSP 
nanoparticles. 
The drug release from nanoparticles is related 
to their chemical and physical properties, such as 
partition coefficient between the drug and hydrophobic 
group, drug diffusion rate, and copolymer degradation 
(Sutthasupa, Sanda, 2016). These results suggested that 
DTX was gradually released from the DTX-AA-CSP 
nanoparticles, and a slower release rate was maintained 
for a relatively longer time. 
Biocompatibility study of the delivery 
carrier (AA-CSP nanoparticles) 
MTT assay was also analyzed on HUVEC 
to investigate the biocompatibility of AA-CSP 
nanoparticles toward normal cells. As shown in Figure 
8, with concentrations of AA-CSP nanoparticles ranging 
from 0.05 mg/mL to 1 mg/mL, the cell viability of 
HUVEC cells were all above 90%, which revealed that 
the nanoparticles were safe to be used as drug carriers 
below 1 mg/mL. According to previous literature, the 
DTX therapeutic concentration was 6.45±1.18 μg/mL 
after intravenous infusion at 1 h at a 75 mg/m2 dose. The 
corresponding carrier material (AA-CSP nanoparticles) 
concentration was 43.58±7.97 μg/mL (Guan et al., 2016 
a or b???). Toxicity results indicated that AA-CSP 
FIGURE 7 - In vitro release profiles of DTX from docetaxel injection (- -) and DTX-AA-CSP nanoparticles (- -) in pH 6.8 
phosphate-buffered saline containing 0.5% of Tween 80 at 37 ± 0.5 °C.
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nanoparticles caused no toxicity below 1 mg/mL. Thus, 
delivery carriers (AA-CSP nanoparticles) were safe and 
biocompatible, which can be used as a promising drug 
delivery system for antitumor drugs.
In vitro anticancer activity
The in vitro anticancer activity of the AA-CSP 
nanoparticles, docetaxel injection and DTX-AA-CSP 
nanoparticles was evaluated via the MTT assay using 
SW480 and HepG2 as a model liver cancer cell line. 
As shown in Figures 9 and 10, docetaxel injection and 
DTX-AA-CSP nanoparticles apparently had dose-
dependent inhibition against HepG2 and SW480 cells at 
an equivalent DTX dose from 0.0005 μg/mL to 0.5 μg/
mL. AA-CSP nanoparticles, Taxotere®, and DTX-AA-
CSP nanoparticles presented similar antitumor activity 
against HepG2 and SW480 cancer cells. 
When AA-CSP nanoparticles concentration 
was 0.5 μg/mL, the anticancer activity of blank AA-
CSP nanoparticles on SW480 and HepG2 cells was 
22.52%±2.03% and 22.56%±1.19%, respectively. 
The blank AA-CSP copolymer micelles were still 
biocompatible, and AA-CSP showed less inhibition 
on cancer cell growth. When DTX concentration was 
0.5 μg/mL, the antitumor activities of DTX-AA-CSP 
nanoparticles and docetaxel injection on SW480 and 
HepG2 cells were 52.96%±1.43% and 43.62%±0.95%, 
respectively, whereas the anticancer activity was 
48.48%±0.57% and 40.92%±2.86% at 0.5 μg/mL drug 
concentration, respectively. The anticancer activities of 
DTX-AA-CSP nanoparticles against HepG2 and SW480 
cancer cells were stronger than those of Taxotere®. 
Results also revealed that DTX-AA-CSP nanoparticles 
were highly effective against tumor cells and improved 
the tumor therapy of free DTX. 
One possible reason for enhanced tumor therapy 
was the property of nanoparticles. Drug-loaded 
nanoparticles have excellent dispersion, large specific 
surface area, and small particle diameter. It is beneficial 
for the improvement of the drug-loaded effect due to 
its large surface energy and chemical activity. At the 
same time, the good compatibility of this nanoparticle 
is favorable to enter cancer cells through endocytosis. 
Nanoparticles with an approximately 100 nm diameter 
improved tumoral uptake by 10–20 folds compared with 
that of other diameters due to its good permeability and 
retention (Moreira, Gaspar, Allen, 2001). DTX-AA-
CSP nanoparticles can take DTX into the cancer cells 
through endocytosis and increase intracellular DTX 
accumulation (Wong et al., 2006). Cancer cells have a 
particular endocytic route and internalize DTX-AA-CSP 
nanoparticles into the interior of the cell, which increase 
drug concentration near the action site (Morrisa et al., 
FIGURE 8 - Biocompatibility measurement of AA-CSP nanoparticles on HUVEC cells.
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FIGURE 9 - Anticancer activity of AA-CSP nanoparticles, docetaxel injection (Taxotere®) and DTX- AA-CSP nanoparticles on 
SW 480 cells after 48 h incubation (* p < 0.05).
FIGURE 10 - Anticancer activity of AA-CSP nanoparticles, docetaxel injection (Taxotere®) and DTX-AA-CSP nanoparticles on 
HepG2 cells after 48 h incubation (* p < 0.05).
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2011). In addition, DTX-AA-CSP nanoparticles probably 
avoid the DTX efflux effect by inhibiting drug efflux 
pumps (e.g. P-glycoprotein [P-gp]), which commonly 
exist in many tumor cells with multidrug resistance. 
However, the intrinsic mechanism of improving tumor 
therapy for DTX-AA-CSP nanoparticles will need 
further investigation in our next work.
CONCLUSION
In this study, a novel amphiphilic copolymer AA-
CSP was synthesized through the covalent attachment 
of AA to CSP derived from TCM and was characterized 
by 1H-NMR and FT-IR. The copolymer can easily 
self-assemble into micelle nanoparticles in an aqueous 
medium. DTX-AA-CSP nanoparticles had a particle 
diameter of 98.91±0.29 nm, LC of 8.09%±0.04%, and 
EE of 80.95%±0.43%. The DTX-AA-CSP nanoparticles 
maintained a relatively longer release time than 
the marketed DTX injection, Taxotere®. AA-CSP 
nanoparticles had good biocompatibility and no toxicity 
at therapeutic concentration toward HUVEC cells. The 
anticancer activity of DTX-AA-CSP nanoparticles 
against HepG2 and SW480 cells was superior to that 
of Taxotere®. Docetaxel injection and DTX-AA-CSP 
nanoparticles apparently inhibit HepG2 and SW480 cells 
in a dose-dependent manner. This work is beneficial 
to the development of polymer micelle nanoparticles 
based on TCM and provides a promising biocompatible 
delivery system (AA-CSP nanoparticle) to carry 
hydrophobic antitumor drugs for cancer therapy.
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